Skip to content
DeepViews

AtriCure, Inc. (ATRC) — 分析摘要

AtriCure, Inc.(ATRC)的市值为2.51十亿美元,最近一年的营收同比增长了+14.9%。净利润率为-2.1%。当前市盈率为237.5倍。

核心要点

  • 营收同比变化+14.9%
  • 净利润率-2.1%
  • 市盈率237.5倍

与SURGICAL & MEDICAL INSTRUMENTS & APPARATUS板块的其他公司相比,ATRC的营收增长为+14.9%,市盈率为237.5倍。

[XNAS]

AtriCure, Inc. (ATRC)

$48.54

更新 — ET · 市场数据 POLYGON · 财务数据 SEC EDGAR

市值
$2506.18M
企业价值
$2399.40M
市盈率
237.5
股息率
0.00%
EV/EBITDA
96.9
公司简介
关于
关于 AtriCure, Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

行业

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

员工人数

1,350

总部

MASON, OH

Exchange

XNAS

官网
Source: Polygon.io
评分
竞争壁垒
竞争壁垒
51
窄护城河

基于 4 年财务数据的系统性竞争优势评估

此评估基于历史财务数据的量化分析,不构成投资建议。护城河评级可能随行业和竞争环境变化。

市场信号
估值
盈利
内部人交易
内部人备案活动

首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。

加载 SEC 内部人备案数据...
超级投资者
财务健康
财务健康

资本结构

总权益$516.43M
总债务$61.00M
债务权益比0.12
现金及等价物$167.79M

现金流

经营现金流$64.94M
自由现金流$53.11M
自由现金流率9.32%
P/FCF 比率47.18
Source: Polygon.io · SEC EDGAR
股息
最新资讯
Recent News

免责声明:本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。